Logo
GRAVES DISEASE OVERACTIVE THYROID MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)
  2. / Industry Reports
  3. Graves Disease Overactive Thyroid Market Analysis
all report title image

GRAVES DISEASE OVERACTIVE THYROID MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Graves’ Disease (Overactive Thyroid) Market By Treatment (Anti-thyroid Drugs, Beta Blockers, Iodine Therapy, Radioactive Iodine Therapy, Others), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Jun 2024
  • Code : CMI7060
  • Pages :135
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Graves’ Disease (Overactive Thyroid) Market Concentration By Players

Close-monitor your Competitor's Move, Get Instant Access to the Report

Key Players Insights
  • AbbVie Inc.
  • Pfizer Inc.
  • RLC LABS, Inc.
  • Merck KGaA
  • Eisai Co., Ltd.
  • Novartis AG
  • Mylan N.V.
  • Aspen Pharmacare Holdings Ltd
  • Sanofi
  • GlaxoSmithKline plc
  • AstraZeneca
  • Horizon Therapeutics plc
  • Alara Pharmaceutical Corporation
  • Antares Pharma, Inc.
  • Apitope Technology (Bristol) Ltd.
  • IONIS Pharmaceuticals, Inc.
  • Immunovant, Inc.
  • HanAll Biopharma Co., Ltd.
  • Cara Therapeutics

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.